| pubmed-article:16424738 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:16424738 | lifeskim:mentions | umls-concept:C0086418 | lld:lifeskim |
| pubmed-article:16424738 | lifeskim:mentions | umls-concept:C0014257 | lld:lifeskim |
| pubmed-article:16424738 | lifeskim:mentions | umls-concept:C0005516 | lld:lifeskim |
| pubmed-article:16424738 | lifeskim:mentions | umls-concept:C0243026 | lld:lifeskim |
| pubmed-article:16424738 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:16424738 | pubmed:dateCreated | 2006-1-20 | lld:pubmed |
| pubmed-article:16424738 | pubmed:abstractText | a) To evaluate in septic patients the blood levels of endocan, a circulating proteoglycan, which regulates leukocyte function-associated antigen-1/intercellular adhesion molecule-1 interactions in vitro; b) to determine whether endocan could be used as a diagnostic and prognostic marker in sepsis in the intensive care unit; and c) to study kinetics of endocan secretion by endothelial cells in vitro after stimulation by soluble mediators involved in sepsis. | lld:pubmed |
| pubmed-article:16424738 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16424738 | pubmed:language | eng | lld:pubmed |
| pubmed-article:16424738 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16424738 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:16424738 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16424738 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16424738 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16424738 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16424738 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:16424738 | pubmed:month | Feb | lld:pubmed |
| pubmed-article:16424738 | pubmed:issn | 0090-3493 | lld:pubmed |
| pubmed-article:16424738 | pubmed:author | pubmed-author:ScherpereelAr... | lld:pubmed |
| pubmed-article:16424738 | pubmed:author | pubmed-author:JourdainMercé... | lld:pubmed |
| pubmed-article:16424738 | pubmed:author | pubmed-author:LassallePhili... | lld:pubmed |
| pubmed-article:16424738 | pubmed:author | pubmed-author:TsicopoulosAn... | lld:pubmed |
| pubmed-article:16424738 | pubmed:author | pubmed-author:GentinaThibau... | lld:pubmed |
| pubmed-article:16424738 | pubmed:author | pubmed-author:TonnelAndre-B... | lld:pubmed |
| pubmed-article:16424738 | pubmed:author | pubmed-author:GrigoriuBogda... | lld:pubmed |
| pubmed-article:16424738 | pubmed:author | pubmed-author:PuginJeromeJ | lld:pubmed |
| pubmed-article:16424738 | pubmed:author | pubmed-author:DepontieuFlor... | lld:pubmed |
| pubmed-article:16424738 | pubmed:author | pubmed-author:CavestriBéatr... | lld:pubmed |
| pubmed-article:16424738 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:16424738 | pubmed:volume | 34 | lld:pubmed |
| pubmed-article:16424738 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:16424738 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:16424738 | pubmed:pagination | 532-7 | lld:pubmed |
| pubmed-article:16424738 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:16424738 | pubmed:meshHeading | pubmed-meshheading:16424738... | lld:pubmed |
| pubmed-article:16424738 | pubmed:meshHeading | pubmed-meshheading:16424738... | lld:pubmed |
| pubmed-article:16424738 | pubmed:meshHeading | pubmed-meshheading:16424738... | lld:pubmed |
| pubmed-article:16424738 | pubmed:meshHeading | pubmed-meshheading:16424738... | lld:pubmed |
| pubmed-article:16424738 | pubmed:meshHeading | pubmed-meshheading:16424738... | lld:pubmed |
| pubmed-article:16424738 | pubmed:meshHeading | pubmed-meshheading:16424738... | lld:pubmed |
| pubmed-article:16424738 | pubmed:meshHeading | pubmed-meshheading:16424738... | lld:pubmed |
| pubmed-article:16424738 | pubmed:meshHeading | pubmed-meshheading:16424738... | lld:pubmed |
| pubmed-article:16424738 | pubmed:meshHeading | pubmed-meshheading:16424738... | lld:pubmed |
| pubmed-article:16424738 | pubmed:meshHeading | pubmed-meshheading:16424738... | lld:pubmed |
| pubmed-article:16424738 | pubmed:meshHeading | pubmed-meshheading:16424738... | lld:pubmed |
| pubmed-article:16424738 | pubmed:meshHeading | pubmed-meshheading:16424738... | lld:pubmed |
| pubmed-article:16424738 | pubmed:year | 2006 | lld:pubmed |
| pubmed-article:16424738 | pubmed:articleTitle | Endocan, a new endothelial marker in human sepsis. | lld:pubmed |
| pubmed-article:16424738 | pubmed:affiliation | INSERM Unit 416, Institut Pasteur de Lille, France. a-scherpereel@chru-lille.fr | lld:pubmed |
| pubmed-article:16424738 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:16424738 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16424738 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16424738 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16424738 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16424738 | lld:pubmed |
